①Uni-President China Holdings Ltd. is expected to achieve a net profit exceeding 2 billion yuan in 2025, what is the growth rate? ②Chuzi City Technology's annual profit increased by approximately 90% year-over-year, what are the highlights?
Cailian Press, March 4 (Editor: Feng Yi) Cailian Press brings you key announcements for Hong Kong stocks today.
1) Corporate News
Uni-President China Holdings Ltd. (00220.HK): Revenue reached 31.714 billion yuan in 2025, an increase of 4.56% year-over-year; net profit was 2.05 billion yuan, up 10.88% year-over-year.
Chuzi City Technology (09911.HK): Total revenue for 2025 is estimated to be between 6.76 billion yuan and 7 billion yuan, representing year-over-year growth of approximately 32.8% to 37.5%. Net profit is projected at 900 million yuan to 940 million yuan, an increase of about 87.5% to 95.8% year-over-year, primarily driven by steady growth in diversified social products powered by AI technology.
Qingci Games (06633.HK): Net profit for 2025 is expected to range from 110 million yuan to approximately 140 million yuan, marking a year-over-year increase of approximately 134% to 197%, mainly due to reduced marketing expenses and increased investment income.
Zhouhei Duck (01458.HK): It is anticipated that total revenue for 2025 will be between 2.52 billion yuan and 2.55 billion yuan, reflecting year-over-year growth of approximately 2.8% to 4.0%; net profit is projected at 150 million yuan to 165 million yuan, an increase of about 52.7% to 68.0% year-over-year.
Myth World (00582.HK): The consolidated net loss for 2025 is expected to decrease by approximately 20% to 35% year-over-year.
China Everbright Green Technology (01257.HK): Issued a positive earnings forecast, expecting net profit for 2025 not to exceed 55 million Hong Kong dollars, reversing losses from the previous year.
Zhihua Group (01842.HK): Issued a profit warning, forecasting that the net loss for fiscal year 2025 will increase year-over-year to approximately 24 million Hong Kong dollars to 26 million Hong Kong dollars.
Lianhua Supermarket (00980.HK): Issued a profit warning, anticipating that the net loss attributable to shareholders for 2025 will narrow by 35% to 55% year-over-year.
China Power (02380.HK): Consolidated total electricity sales in January amounted to 10.4595 million megawatt-hours, representing a 4.79% increase compared to the same period last year.
Jinshang Bank (02558.HK): Completed the transfer of a series of non-performing assets for RMB 310 million.
Hutchison China MediTech (00013.HK): Initiated a global study of HMPL-A580, a PI3K/PIKK-EGFR ATTC candidate drug, for the treatment of solid tumors.
Simu Technology (02571.HK): Submitted a filing application to the China Securities Regulatory Commission for the implementation of full H-share convertibility.
CSPC Pharma (01093.HK): Emicizumab Injection (SYS 6053) received clinical trial approval in China.
Hengrui Pharma (01276.HK): Received clinical trial approval notices for SHR-A2102 for injection and SHR-8068 injection. Global sales of similar drugs in 2024 are projected to reach approximately USD 3.271 billion.
Zhongsheng Pharmaceutical (00867.HK): Independently developed CMS-D008, an INHBE small nucleic acid drug for overweight or obesity indications, has received clinical trial approval notice.
Binhai Investment (02886.HK): Strengthened investment from Tianjin Teda and Sinopec to deepen its natural gas and clean energy layout.
Xingye Holdings (00132.HK): Subsidiary entered into a financial lease agreement for certain designated wastewater treatment equipment and facilities.
2) Updates on shareholding changes and share repurchases
CNOOC Ltd. (00883.HK): From October 9, 2025, to March 4, 2026, the actual controller, CNOOC Group, cumulatively increased its shareholding by 25.0035 million shares.
Geely Auto (00175.HK): Repurchased 7.378 million shares at a cost of HKD 112 million, with repurchase prices ranging from HKD 14.97 to HKD 15.41 per share.
Midea Group (00300.HK): Repurchased 650,400 A-shares at a cost of RMB 49.3663 million, with repurchase prices ranging from RMB 75.44 to RMB 76.49 per share.
Xindong Company (02400.HK): Repurchased 110,000 shares at a cost of HKD 7.8216 million, with repurchase prices ranging from HKD 69.85 to HKD 73.85 per share.
